Schering-Plough Loses Suit Over Laxative Marketing
The case involves MiraLax, an over-the-counter oral laxative marketed by Schering-Plough. The company had sued four companies that produce a generic, prescription version of the same drug, polyethylene glycol 3350.
Schering-Plough alleged that in marketing their product as “prescription only,” the defendants were...
To view the full article, register now.